Using depression and suicide screenings and other resources can help save lives
Sep. 2024Important Notices
Caring for your patients’ mental health needs is essential to their overall well-being. You can use these and other processes and resources to support their behavioral health needs.
- Implement the National Institute of Mental Health action steps for helping someone in emotional pain:
- Ask: Are you thinking about harming yourself?
- Keep them safe: Reduce access to lethal items or places. Be there: Listen carefully and acknowledge their feelings.
- Help them connect: Call or text the 988 Suicide and Crisis Lifeline at 988.
- Stay connected: Stay in touch after a crisis.
- Take free continuing medical education (CME) courses centered around suicide and depression to help you increase the depth and quality of care you provide: These activities are approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in these activities.
- Know about other tools that can help you provide appropriate support:
- Crisis hotlines, such as Trevor Lifeline 24/7 crisis support for LGBTQIA+ youth and Trans Lifeline24/7 crisis and peer support
- Behavioral health resources, such as:
- National Institute of Mental Health
- Zero Suicide: Screen/Assess
- American Foundation for Suicide Prevention
- American Academy of Pediatrics
- Columbia Suicide Severity Rating Scale (C-SSRS)
- Ask Suicide-Screen Questions (ASQ) for ages 10-24
- Suicide Assessment Five-Step Evaluation and Triage (SAFE-T)
- Telephonic Psychiatric Consultation Service Program for PA Medical Assistance
Recent Announcements
October 2025 UPMC for You and UPMC Community HealthChoices formulary update
Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.Oct. 2025Pharmacy Updates
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates
HelpScript service helps patients enroll in manufacturer copay assistance programs
End-to-end provider support helps ensure a smooth submission processOct. 2025Important Notices